Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01875978
What this trial is testing

Effect of Phytosterols on Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
China Medical University Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06623539
What this trial is testing

Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
Yokohama City University 360
Testing effectiveness (Phase 2)Study completedNCT04235205
What this trial is testing

Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
Yokohama City University 102
Not applicableUnknownNCT03463967
What this trial is testing

Effects of Tomato Products in Children With NAFLD

Who this might be right for
NAFLD
Federico II University 61
Large-scale testing (Phase 3)Study completedNCT00063635
What this trial is testing

Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)

Who this might be right for
Fatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 173
Testing effectiveness (Phase 2)Study completedNCT03459079
What this trial is testing

Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)Type 2 Diabetes (T2DM)
University of Florida 128
Not applicableActive Not RecruitingNCT07007741
What this trial is testing

Digital Therapy for Fatty Liver Disease

Who this might be right for
Steatohepatitis, NonalcoholicNonalcoholic Fatty Liver
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 141
Not applicableStudy completedNCT03067428
What this trial is testing

Effects of Fructose Restriction on Liver Steatosis

Who this might be right for
Nonalcoholic Fatty Liver DiseaseGlucose Metabolism DisordersEndothelial Dysfunction
Maastricht University Medical Center 44
Testing effectiveness (Phase 2)Study completedNCT00266019
What this trial is testing

Weight Management in Nonalcoholic Steatohepatitis

Who this might be right for
Fatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Not applicableStudy completedNCT05320146
What this trial is testing

A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Corcept Therapeutics 22
Not applicableUnknownNCT05041673
What this trial is testing

Anti-diabetic Drugs and Fatty Liver Management

Who this might be right for
Fatty Liver, NonalcoholicDiabetes Mellitus, Type 2
Alexandria University 120
Not applicableStudy completedNCT03512184
What this trial is testing

YMCA Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Weight LossNAFLDLiver Diseases
Weill Medical College of Cornell University 48
Testing effectiveness (Phase 2)Ended earlyNCT03868566
What this trial is testing

An Open-Label Study to Assess the Hepatic Protection Effect of SNP-612, in Patients With NAFLD

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Sinew Pharma Inc. 90
Large-scale testing (Phase 3)UnknownNCT00303537
What this trial is testing

Metformin in Non-Alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver
University Hospital, Aker 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT05979779
What this trial is testing

Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisFatty Liver
Rivus Pharmaceuticals, Inc. 219
Testing effectiveness (Phase 2)Ended earlyNCT03294941
What this trial is testing

The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
HepQuant, LLC 17
Not applicableTemporarily pausedNCT02506946
What this trial is testing

NAFLD in Adolescents and Young Adults With PCOS

Who this might be right for
Polycystic Ovary SyndromeNon-Alcoholic Fatty Liver DiseaseMetabolic Syndrome
Columbia University 80
Not applicableLooking for participantsNCT06975579
What this trial is testing

The COherence of Scatter Identification and Exclusion Algorithm Study

Who this might be right for
Steatohepatitis, Nonalcoholic
Institute of Cancer Research, United Kingdom 15
Testing effectiveness (Phase 2)Ended earlyNCT00529204
What this trial is testing

Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease

Who this might be right for
Diabetes ComplicationsFatty Liver
University of California, Davis 1
Testing effectiveness (Phase 2)Study completedNCT02442687
What this trial is testing

JKB-121 for the Treatment of Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
Manal Abdelmalek 65
Next Page